Molecular modelling of human CYP2C subfamily enzymes CYP2C9 and CYP2C19: rationalization of substrate specificity and site-directed mutagenesis experiments in the CYP2C subfamily

By Lewis D. F. V.   Dickins M.   Weaver R. J.   Eddershaw P. J.   Goldfarb P. S.   Tarbit M. H.  

Xenobiotica, Vol. 28, Iss. 3, 1998-03 ,pp. : 235-268

Informa Healthcare

Access to resources Recommend Favorite

Inhibitory effects of phthalimide derivatives on the activity of the hepatic cytochrome P450 monooxygenases CYP2C9 and CYP2C19

By Kolukisaoglu Üner   Wendler Christian   Goerdes Dirk   Diener Annette   Thurow Kerstin  

Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 25, Iss. 6, 2010-12 ,pp. : 876-886

Informa Healthcare

Access to resources Recommend Favorite

Characterization of CYP2C19 and CYP2C9 from Human Liver: Respective Roles in Microsomal Tolbutamide, S-Mephenytoin, and Omeprazole Hydroxylations

By Lasker J.M.   Wester M.R.   Aramsombatdee E.   Raucy J.L.  

Archives of Biochemistry and Biophysics, Vol. 353, Iss. 1, 1998-05 ,pp. : 16-28

Elsevier

Access to resources Recommend Favorite

Effect of glycyrrhizin on CYP2C19 and CYP3A4 activity in healthy volunteers with different CYP2C19 genotypes

By Tu J.-H.   Hu D.-L.   Dai L.-L.   Sun Y.   Fan L.   Zhang M.   Tan Z.-R.   Chen Y.   Li Z.   Zhou H.-H.  

Xenobiotica, Vol. 40, Iss. 6, 2010-06 ,pp. : 393-399

Informa Healthcare

Access to resources Recommend Favorite

Different effects of proton pump inhibitors and famotidine on the clopidogrel metabolic activation by recombinant CYP2B6, CYP2C19 and CYP3A4

By Ohbuchi Masato   Noguchi Kiyoshi   Kawamura Akio   Usui Takashi  

Xenobiotica, Vol. 42, Iss. 7, 2012-07 ,pp. : 633-640

Informa Healthcare

Access to resources Recommend Favorite